|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 2 609-R614, Copyright © 1997 by American Physiological Society
ARTICLES |
B. J. MacNeil, A. H. Jansen, L. J. Janz, A. H. Greenberg and D. M. Nance
Department of Pathology, University of Manitoba, Winnipeg, Canada.
We tested whether prostaglandin synthesis mediates the lipopolysaccharide (LPS)-induced increase in splenic sympathetic nerve activity. Sprague-Dawley rats were pretreated with intravenous or intracerebroventricular injections of indomethacin, and splenic nerve activity was recorded after intravenous injections of LPS. In vehicle-pretreated rats, 100 micrograms LPS induced a 62.8 +/- 5.6% increase in splenic nerve activity beginning 22.7 +/- 2.7 min postinjection. All vehicle-pretreated animals responded to high (100 micrograms, 5 of 5 animals) and low (10 micrograms, 8 of 8 animals) doses of LPS. Both intravenous (15 mg/kg) and intracerebroventricular (50 micrograms) pretreatments with indomethacin delayed (F1.19 = 30.66, P < 0.001) the increase in nerve activity after 100 micrograms LPS. When given intravenously, 50 micrograms indomethacin (the intracerebroventricular dose) did not delay the response to intravenous LPS, indicating that the effects of intracerebroventricular indomethacin pretreatment were restricted to the central nervous system. Importantly, intracerebroventricular indomethacin reduced (2 of 7 animals) or completely blocked (5 of 7 animals) the splenic nerve response to the low dose of LPS (10 micrograms, iv). The indomethacin effects could not be accounted for by central release of vasopressin because intracerebroventricular injection of indomethacin did not alter baseline nerve activity or blood pressure, whereas intracerebroventricular injection of vasopressin rapidly increased both measures. Additionally, central injection of LPS did not elevate splenic nerve activity, whereas intracerebroventricular injection of prostaglandin E2 induced a rapid (2.2 +/- 2.7 min) increase in splenic nerve activity. These data indicate that central prostaglandin synthesis is an intermediate step whereby systemic LPS elicits an increase in sympathetic outflow to an immune organ.
This article has been cited by other articles:
![]() |
Y. Wang, M. Novotny, V. Quaiserova-Mocko, G. M. Swain, and D. H. Wang TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1517 - R1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Zhang, S.-G. Wei, J. Francis, and R. B. Felder Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R916 - R927. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Felder, J. Francis, Z.-H. Zhang, S.-G. Wei, R. M. Weiss, and A. K. Johnson Heart failure and the brain: new perspectives Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R259 - R276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Kohm and V. M. Sanders Norepinephrine and beta 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in Vivo Pharmacol. Rev., December 1, 2001; 53(4): 487 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Andrew and S. Kaufman Splenic denervation worsens lipopolysaccharide-induced hypotension, hemoconcentration, and hypovolemia Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1564 - R1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. MacNeil, A. H. Jansen, A. H. Greenberg, and D. M. Nance Effect of acute adrenalectomy on sympathetic responses to peripheral lipopolysaccharide or central PGE2 Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1321 - R1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Porter, B. J. Hrupka, W. Langhans, and G. J. Schwartz Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta , LPS, and MDP Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R384 - R389. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |